Literature DB >> 15295145

Virtual reality and psychotherapy.

Cristina Botella1, Soledad Quero, Rosa M Baños, Conxa Perpiñá, Azucena García Palacios, Giuseppe Riva.   

Abstract

Virtual Reality (VR) is a new technology consisting on a graphic environment in which the user, not only has the feeling of being physically present in a virtual world, but he/she can interact with it. The first VR workstations were designed for big companies in order to create environments that simulate certain situations to train professionals. However, at this moment a great expansion of this technology is taking place in several fields, including the area of health. Especially interesting for us is the use of VR as a therapeutic tool in the treatment of psychological disorders. Compared to the traditional treatments, VR has many advantages (e.g., it is a protected environment for the patient, he/she can re-experience many times the feared situation, etc.). There are already data on the effectiveness of this technology in the treatment of different psychological disorders; here anxiety disorders, eating disorders and sexual disorders are reviewed. Finally, this chapter ends with some words about the limitations of VR and future perspectives.

Entities:  

Mesh:

Year:  2004        PMID: 15295145

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  14 in total

1.  Virtual Worlds versus Real Body: Virtual Reality Meets Eating and Weight Disorders.

Authors:  Giuseppe Riva; José Gutiérrez-Maldonado; Brenda K Wiederhold
Journal:  Cyberpsychol Behav Soc Netw       Date:  2016-02

2.  Assessment of the emotional responses produced by exposure to real food, virtual food and photographs of food in patients affected by eating disorders.

Authors:  Alessandra Gorini; Eric Griez; Anna Petrova; Giuseppe Riva
Journal:  Ann Gen Psychiatry       Date:  2010-07-05       Impact factor: 3.455

Review 3.  The key to unlocking the virtual body: virtual reality in the treatment of obesity and eating disorders.

Authors:  Giuseppe Riva
Journal:  J Diabetes Sci Technol       Date:  2011-03-01

4.  The use of virtual complementary and integrative therapies by neurology outpatients: An exploratory analysis of two cross-sectional studies assessing the use of technology as treatment in an academic neurology department in New York City.

Authors:  Mia T Minen; Neil A Busis; Steven Friedman; Maya Campbell; Ananya Sahu; Kazi Maisha; Quazi Hossain; Mia Soviero; Deepti Verma; Leslie Yao; Farng-Yang A Foo; Jaydeep M Bhatt; Laura J Balcer; Steven L Galetta; Sujata Thawani
Journal:  Digit Health       Date:  2022-07-17

5.  Interreality: the experiential use of technology in the treatment of obesity.

Authors:  Riva G; Wiederhold B K; Mantovani F; Gaggioli A
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-03-04

6.  Client perceptions of the mental health engagement network: a qualitative analysis of an electronic personal health record.

Authors:  Cheryl Forchuk; Jeffrey P Reiss; Tony O'Regan; Paige Ethridge; Lorie Donelle; Abraham Rudnick
Journal:  BMC Psychiatry       Date:  2015-10-14       Impact factor: 3.630

7.  Using Virtual Reality in the Inference-Based Treatment of Compulsive Hoarding.

Authors:  Marie-Eve St-Pierre-Delorme; Kieron O'Connor
Journal:  Front Public Health       Date:  2016-07-19

Review 8.  Transforming Experience: The Potential of Augmented Reality and Virtual Reality for Enhancing Personal and Clinical Change.

Authors:  Giuseppe Riva; Rosa M Baños; Cristina Botella; Fabrizia Mantovani; Andrea Gaggioli
Journal:  Front Psychiatry       Date:  2016-09-30       Impact factor: 4.157

9.  Individuals with severely impaired vision can learn useful orientation and mobility skills in virtual streets and can use them to improve real street safety.

Authors:  Ellen Lambert Bowman; Lei Liu
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

10.  Virtual reality exposure using three-dimensional images for the treatment of social phobia.

Authors:  Cristiane M Gebara; Tito P de Barros-Neto; Leticia Gertsenchtein; Francisco Lotufo-Neto
Journal:  Braz J Psychiatry       Date:  2015-11-13       Impact factor: 2.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.